CGM approved by FDA for adults with diabetes; U.S. launch set for late 2025 with extended wear and advanced tracking features ...

Dexcom (Nadsaq:DXCM) announced today that the FDA cleared its G7 15-day continuous glucose monitoring (CGM) system.

The Dexcom G7 15 Day CGM system is a wearable sensor that continuously measures glucose levels and transmits readings every 5 minutes with no fingersticks or scanning required.

DexCom (DXCM) announced the FDA has cleared the Dexcom G7 15 Day continuous glucose monitoring system for people over the age of 18 with ...

Dexcom launched its first over-the-counter continuous glucose monitor called Stelo on Monday ... to patients with diabetes since they can help alert users, their loved ones and their doctors ...

The Dexcom G7 CGM sensor needs only 30 minutes to warm up, and there is a 12-hour grace period to replace finished sensors for a seamless transition between sessions. The alert settings on the ...

Select continuous glucose monitoring systems, such as Dexcom G7 and Dexcom G6, are equipped with a predictive Urgent Low Soon alert that can warn users up to 20 minutes in advance of a severe ...